PMID- 36043339 OWN - NLM STAT- MEDLINE DCOM- 20230110 LR - 20230208 IS - 1096-9071 (Electronic) IS - 0146-6615 (Print) IS - 0146-6615 (Linking) VI - 95 IP - 1 DP - 2023 Jan TI - A significant predictor of in-hospital and long-term mortality and progression in COVID-19 patients: The end-stage liver disease (MELD) score model. PG - e28109 LID - 10.1002/jmv.28109 [doi] AB - The aim of this study is to investigate the relationship between the model for end-stage liver disease (MELD) score and disease progression and mortality in COVID-19 patients. The files of 4213 patients over the age of 18 who were hospitalized with the diagnosis of COVID-19 between March 20, 2020 and May 1, 2021 were retrospectively scanned. Sociodemographic characteristics, chronic diseases, hemogram and biochemical parameters at the time they were diagnosed with COVID-19 of the patients, duration of hospitalization, duration of intensive care unit (ICU), duration of intubation, in-hospital mortality from COVID-19 and outside-hospital mortality for another reason (within the last 1 year) and recurrent hospitalization (within the last 1 year) were recorded. The MELD scores of the patients were calculated. Two groups were formed as MELD score < 10 and MELD score >/= 10. The rate of ICU, in-hospital mortality from COVID-19 and outside-hospital mortality from other causes, intubation rate, and recurrent hospitalization were significantly higher in the MELD >/= 10 group. The duration of ICU, hospitalization, intubation were significantly higher in the MELD >/= 10 group (p < 0.001). As a result of Univariate and Multivariate analysis, MELD score was found to be the independent predictors of ICU, in-hospital mortality, intubation, and recurrent hospitalization (p < 0.001). MELD score 18.5 predicted ICU with 99% sensitivity and 100% specificity (area under curve [AUC]: 0.740, 95% confidence interval [CI]: 0.717-0.763, p < 0.001) also MELD score 18.5 predicted in-hospital mortality with 99% sensitivity and 100% specificity (AUC: 0.797, 95% CI: 0.775-0.818, p < 0.001). The MELD score was found to be the independent predictors of in-hospital mortality, ICU admission, and intubation in COVID-19 patients. CI - (c) 2022 Wiley Periodicals LLC. FAU - Kaya, Yasemin AU - Kaya Y AUID- ORCID: 0000-0001-7360-8090 AD - Department of Internal Medicine, Ordu University Medical Faculty, Ordu, Turkey. FAU - Gulcu, Oktay AU - Gulcu O AD - Erzurum Regional Training and Research Hospital, Erzurum, Turkey. FAU - Aksakal, Emrah AU - Aksakal E AD - Erzurum Regional Training and Research Hospital, Erzurum, Turkey. FAU - Kalkan, Kamuran AU - Kalkan K AD - Erzurum Regional Training and Research Hospital, Erzurum, Turkey. FAU - Aydin, Sidar S AU - Aydin SS AD - Erzurum Regional Training and Research Hospital, Erzurum, Turkey. FAU - Kaya, Ahmet AU - Kaya A AD - Department of Cardiology, Ordu University Medical Faculty, Ordu, Turkey. FAU - Bostan, Sedat AU - Bostan S AD - Health Care Management Department, Faculty of Health Science, Karadeniz Techinical University, Trabzon, Turkey. LA - eng PT - Journal Article DEP - 20220910 PL - United States TA - J Med Virol JT - Journal of medical virology JID - 7705876 SB - IM MH - Humans MH - Adult MH - Middle Aged MH - *End Stage Liver Disease/diagnosis MH - Severity of Illness Index MH - Retrospective Studies MH - Prognosis MH - *COVID-19/diagnosis/complications MH - Hospitals PMC - PMC9539042 OTO - NOTNLM OT - COVID-19 OT - in-hospital mortality OT - intensive care unit admission COIS- The authors declare no conflict of interest. EDAT- 2022/09/01 06:00 MHDA- 2023/01/11 06:00 PMCR- 2022/09/10 CRDT- 2022/08/31 03:44 PHST- 2022/08/13 00:00 [revised] PHST- 2022/06/26 00:00 [received] PHST- 2022/08/27 00:00 [accepted] PHST- 2022/09/01 06:00 [pubmed] PHST- 2023/01/11 06:00 [medline] PHST- 2022/08/31 03:44 [entrez] PHST- 2022/09/10 00:00 [pmc-release] AID - JMV28109 [pii] AID - 10.1002/jmv.28109 [doi] PST - ppublish SO - J Med Virol. 2023 Jan;95(1):e28109. doi: 10.1002/jmv.28109. Epub 2022 Sep 10.